(Adds details on sales, guidance in bullets 1-4) Nov 3 (Reuters) – French biotechnology firm Biomérieux reported on Tuesday a better-than-expected organic sales growth in the third quarter, helped by
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Alun John and Jiaxing Li LONDON/HONG KONG, Nov 3 (Reuters) - The dollar eased…
BRUSSELS, Nov 3 (Reuters) - An adviser to Europe's highest court said on Tuesday that…
Nov 3 (Reuters) - Starlite Holdings Ltd: * EXPECTS LOSS ATTRIBUTABLE OF NOT MORE THAN…
MOSCOW, Nov 3 (Reuters) - The Kremlin said on Tuesday it hoped arrangements for a…
VIDEO SHOWS: ARCHIVE SHOTS AND STILLS OF NUNO ESPIRITO SANTO COMPLETE SCRIPT TO FOLLOW SHOWS:…
BRUSSELS, Nov 3 (Reuters) - An adviser to Europe's highest court said on Tuesday that…